Philip Morris International Inc.

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 2,811 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• Altria is not recorded as a holding, per the brief. PMI's Q2 2026 10-Q was searched for any equity relationship with Altria and found none: the only disclosed ties are a Distribution Agreement under which PMI indemnifies Altria and Philip Morris USA for certain tobacco product claims, and a now-ended commercial agreement covering IQOS distribution in the U.S. that terminated April 30, 2024. PMI was spun off from Altria in 2008; the companies are separately owned and there is no cross-shareholding in either direction.
• Swedish Match AB, acquired by PMI in November 2022, is a wholly owned operating subsidiary and is excluded from holdings per the brief.
• Philip Morris India Trading Private Ltd (56.3% PMI-owned, formerly IPM India) and United Tobacco Company (UTC, 54.25% PMI-owned since May 2024, up from a 25% equity-method interest held since April 2023) are both majority-owned and consolidated by PMI. They are excluded from holdings as controlled operating subsidiaries, not minority equity stakes, consistent with the brief's exclusion of wholly owned/controlled operating businesses.
• PMI discloses a combined balance for 'equity security investments in India and Sri Lanka': fair value of $983 million at June 30, 2026 and $1,291 million at December 31, 2025, classified as Level 1 and reported through equity investments and securities (income)/loss, net. The Q2 2026 10-Q does not name the individual investees or split the balance between India and Sri Lanka (or between issuers within each country). Per the brief's rule against sizing a single investee from a combined balance, no individual holding is recorded for this bucket; the combined figure is carried here and in unknowns instead.
• PMI's Q2 2026 10-Q discloses total equity method investments of $1,008 million at June 30, 2026 ($1,019 million at December 31, 2025), and separately states that the carrying value of equity method investments exceeded PMI's share of the investees' underlying book value by $1,023 million at June 30, 2026. In the same filing's market-risk disclosures, TKM alone is given a book value of $0.8 billion and STAEM a book value of $0.7 billion at June 30, 2026, which together already exceed the $1,008 million total. This is an internal inconsistency in the source document that could not be resolved within the task; both the individual investee figures and the total are recorded as filed, and a reader should treat the TKM and STAEM dollar figures as directionally sourced but not perfectly reconcilable to the aggregate line.
• TKM's disclosed book value roughly tripled from $303 million at December 31, 2025 to $0.8 billion at June 30, 2026 per the same 10-Q section (Item 3). No explanation for the increase (for example a capital contribution, a change in measurement basis, or a large offsetting currency swing against the concurrently disclosed $0.5 billion of cumulative translation losses) was found in the filing.
• Register percentages use three different share-outstanding denominators depending on the source's own as-of date: 1,556,656,689 (December 31, 2025, per PMI's FY2025 10-K stockholders' equity roll-forward) for Vanguard's 13F; 1,558,613,439 (July 17, 2026, per the Q2 2026 10-Q cover page) for all other June 30, 2026 13F rows; and 1,558,530,268 (March 13, 2026, as stated directly in PMI's 2026 proxy) for the two proxy-sourced rows (Capital International Investors and the officers/directors group).
• Vanguard's own Form 13F-HR for the quarter ended December 31, 2025 (145,262,397 shares) is used in preference to PMI's proxy, which cites a stale Schedule 13G/A (136,061,098 shares, 8.57%, as of December 29, 2023). Vanguard filed Form 13F-NT (notice, no holdings) for the quarters ended March 31, 2026 and June 30, 2026 under CIK 0000102909, so no more current Vanguard figure is available from that CIK; this mirrors the Broadcom research file's finding for the same manager.
• BlackRock's proxy-cited Schedule 13G/A (98,743,351 shares, 6.22%, as of December 31, 2023) is also stale; the register instead uses BlackRock, Inc.'s own Form 13F-HR for the quarter ended June 30, 2026 (108,039,522 shares).
• Capital World Investors and Capital International Investors are both part of the Capital Group / American Funds complex and are reported as separate 5%+ owners in PMI's proxy; they are treated as distinct holders here because the proxy and EDGAR both file them under separate legal names and, where checked, separate CIKs, with no disclosed parent/subsidiary roll-up relationship stated in the proxy. They are not marked as an aggregate/rolls_up_into pair because no filing found in this task states one contains the other.
• PMI has a single class of common stock, no par value, one vote per share; there is no dual-class structure and no founder control block. The company was spun off from Altria Group in 2008.
• The 14 institutional register rows plus the officers/directors group sum to approximately 50.3% of shares outstanding on their respective denominators; this is not additive across differing as-of dates and share bases and should be read as a rough coverage indicator only, not a precise aggregate.